|
1
|
Ji JZ, Elyaman W, Yip HK, Lee VW, Yick LW
and Hugon J: The possible involvement of STAT3 pathway. Eur J
nerurosci. 19:265–272. 2004. View Article : Google Scholar
|
|
2
|
Ciotu IM, Stoian I, Gaman L, Popescu MV
and Atanasiu V: Biochemical changes and treatment in glaucoma. J
Med Life. 8:28–31. 2015.PubMed/NCBI
|
|
3
|
Heinrich PC, Behrmann I, Haan S, Hermanns
HM, Müller-Newen G and Schaper F: Principles of interleukin
(IL)-6-type cytokine signalling and its regulation. Biochem J.
374:1–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamauchi-Takihara K: Gp130-mediated
pathway and let ventricular remodeling. J Card Fail. 8(6 Suppl):
S374–S378. 2002. View Article : Google Scholar
|
|
5
|
Auernhammer CJ and Melmed S:
Leukemia-inhibitory factor-neuroimmnue modulator of endocrine
function. Endocr Rev. 21:313–345. 2000.PubMed/NCBI
|
|
6
|
Oh H, Fujio Y, kunisada K, Hirota H,
Matsui H, Kishimoto T and Yamauchi-Takihara K: Activation of
phosphatidylinositol 3-kinase through glycoprotein 130 induces
protein kinase B and p70 s6 kinase phosphorylation in cardiac
myocytes. J Biol Chem. 273:9703–9710. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheema SS, Richards L, Murphy M and
Bartlett PF: Leukemia inhibitory factor prevents the death of
axotomised sensory neurons in the dorsal root ganglia of the
neonatal rat. J Neurosci Res. 37:213–218. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mckay Hart A, Wiberg M and Terenghi G:
Exogenous leukemia inhibitory factor enhances nerve regeneration
after late secondary repair using a bioartificial nerve conduit. Br
J plast surg. 56:444–450. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gresle MM, Alexandrou E, Wu Q, Egan G,
Jokubaitis V, Ayers M, Jonas A, Doherty W, Friedhuber A, Shaw G, et
al: Leukemia inhibitory factor protects axons in experimental
autoimmune encephalomyelitis via an oligodendrocyte-independent
mechanism. PLoS One. 7:e473792012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bürgi S, Samardziia M and Grimm C:
Endogenous leukemia inhibitory factor protects photoreceptor cells
against light-induced degeneration. Mol Vis. 15:1631–1637.
2009.PubMed/NCBI
|
|
11
|
Joly S, Lange C, Thiersch M, Samardzija M
and Grimm C: Leukemia inhibitory factor extends the lifespan of
injured photo-receptors in vivo. J Neurosci. 28:13765–13774. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mayer M, Bhakoo K and Noble M: Ciliary
nerrotrophic factor and leukemia inhibitory factor promote the
generation, maturation and survival of oligodendrocytes in vitro.
Development. 120:143–153. 1994.PubMed/NCBI
|
|
13
|
Johnson EC, Doser TA, Cepurna WO, Dyck JA,
Jia L, Guo Y, Lambert WS and Morrison JC: Cell proliferation and
interleukin-6-type cytokine signaling are implicated by gene
expression responses in early optic nerve head injury in rat
glaucoma. Invest Ophthalmol Vis Sci. 52:504–518. 2011. View Article : Google Scholar :
|
|
14
|
Johnson TV and Tomarev SI: Rodent models
of glaucoma. Brain Res Bull. 81:349–358. 2010. View Article : Google Scholar :
|
|
15
|
Metcalf D: The unsolved enigmas of
leukemia inhibitory factor. Stem Cells. 21:5–14. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Piguet-Pellorce C, Dorval-Coiffec I, Pham
MD and Jégou B: Leukemia inhibitory factor expression and
regulation within the testis. Endocrinonlogy. 141:1136–1141. 2000.
View Article : Google Scholar
|
|
17
|
Sariola H: The neurotrophic factors in
non-neuronal tissues. Cell Mol Life Sci. 58:1061–1066. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Williams RL, Hilton DJ, Pease S, Willson
TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA and
Gough NM: Myeloid leukemia inhibitory factor maintains the
developmental potential of embryonic stem cells. Nature.
336:684–687. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smith AG, Health JK, Donaldson DD, Wong
GG, Moreau J, Stahl M and Rogers D: Inhibition of pluripotential
embryonic stem cell differentiation by purified polypeptides.
Nature. 336:688–690. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reid LR, Lowe C, Cornish J, Skinner SJ,
Hilton DJ, Willson TA, Gearing DP and Martin TJ: Leukemia
inhibitory factor: A novel bone-active cytokine. Endocrinology.
126:1416–1420. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dazai S, Akita S, Hirano A, Rashid MA,
Naito S, Akino K and Fujii T: Leukemia inhibitory factor enhances
bone formation in calvarial bone defect. J Craniofac Srug.
11:513–520. 2000. View Article : Google Scholar
|
|
22
|
Dowsing BJ, Hayes A, Bennett TM, Morrison
WA and Messina A: Effects of LIF dose and laminin plus fibronectin
on axotomized sciatic nerves. Muscle Nerve. 23:1356–1364. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cafferty WB, Gardiner NJ, Gavazzi I,
Powell J, McMahon SB, Heath JK, Munson J, Cohen J and Thompson SW:
Leukemia inhibitory factor determines the growth status of injured
adult sensory neurons. J Neurosci. 21:7161–7170. 2001.PubMed/NCBI
|
|
24
|
Bauer S, Rasika S, Han J, Mauduit C,
Raccurt M, Morel G, Jourdan F, Benahmed M, Moyse E and Patterson
PH: Leukemia inhibitory factor is a key signal for injury-induced
neurogenesis in the adult mouse olfactory epithelium. J Neurosci.
23:1792–1803. 2003.PubMed/NCBI
|
|
25
|
Pan S, Li L, Xu Z and Zhao J: Effect of
leukemia inhibitory factor on corneal nerve regeneration of rabbit
eyes after laser in situ keratomileusis. Neurosci Lett. 499:99–103.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chollangi S, Wang J, Martin A, Quinn J and
Ash JD: Preconditioning-induced protection from oxidative injury is
mediated by leukemia inhibitory factor receptor (LIFR) and its
ligands in the retina. Neurobiol Dis. 34:535–544. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ueki Y, Le YZ, Chollangi S, Muller W and
Ash JD: Preconditioning-induced protection of photoreceptors
requires activation of the signal-transducing receptor gp130 in
photoreceptors. Proc Natl Acad Sci USA. 106:21389–21394. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Davis S, Aldrich TH, Stahl N, Pan L, Taga
T, Kishimoto T, Ip NY and Yancopoulos GD: LIRR beta and gp130 as
heterodimerizing signal transducers of the tripartite CNTF
receptor. Science. 260:1805–1808. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pennica D, Shaw KJ, Swanson TA, Moore MW,
Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF and Wood
WI: Cardiotrophin-1. Biological activities and binding to the
leukemia inhibitory factor receptor/gp130 signaling complex. J Biol
Chem. 270:10915–10922. 1995.PubMed/NCBI
|
|
30
|
Gearing DP and Bruce AG: Oncostatin M
binds the high-affinity leukemia inhibitory factor receptor. New
Biol. 4:61–65. 1992.PubMed/NCBI
|
|
31
|
Plun-Favreau H, Perret D, Diveu C, Froger
J, Chevalier S, Lelièvre E, Gascan H and Chabbert M: Leukemia
inhibitory factor (LIF), cardiotrophin-1 and oncostatin M share
structural binding determinants in the immunoglobulin-like domain
of LIF receptor. J Biol Chem. 278:27169–27179. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ju WK, Lee MY, Hofmann HD, Kirsch M, Oh
SJ, Chung JW and Chun MH: Increased expression of ciliary
neurotrophic factor receptor alpha mRNA in the ischemic rat retina.
Neurosci Lett. 283:133–136. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jomary C, Cullen J and Jones SE:
Inactivation of the Akt survival pathway during photoreceptor
apoptosis in the retinal degeneration mouse. Invest Ophthalmol Vis
Sci. 47:1620–1629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hideshima T, Nakamura N, Chauhan D and
Anderson KC: Biologic sequelae of interleukin-6 induced PI3-K/Akt
signaling in multiple myeloma. Oncogene. 20:5991–6000. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jee SH, Chiu HC, Tsai TF, Tsai WL, Liao
YH, Chu CY and Kuo ML: The phosphotidyl inositol 3-kinase/Akt
signal pathway is involved in interleukin-6-mediated Mcl-1
upregulation and anti-apoptosis activity in basal cell carcinoma
cells. J Invest Dermatol. 119:1121–1127. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen J, Fujii K, Zhang L, Roberts T and Fu
H: Raf-1 promotes cell survival by antagonizing apoptosis
signal-regulating kinase 1 through a MEK-ERK independent mechanism.
Proc Natl Acad Sci USA. 98:7783–7788. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sweatt JD: The neuronal MAP kinase
cascade: A biochemical signal integration system subserving
synaptic plasticity and memory. J Neurochem. 76:1–10. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Roth S, Shaikh AR, Hennelly MM, Li Q,
Bindokas V and Graham CE: Mitogen-activated protein kinases and
retinal ischemia. Invest Ophthalmol Vis Sci. 44:5383–5395. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Namura S, Iihara K, Takami S, Nagata I,
Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV and
Alessandrini A: Intravenous administration of MEK inhibitor U0126
affords brain protection against forebrain ischemia and focal
cerebral ischemia. Proc Natl Acad Sci USA. 98:11569–11574. 2001.
View Article : Google Scholar : PubMed/NCBI
|
